Christopher Heery serves as Executive at PRECISION BIOSCIENCES INC, where they oversee executive responsibilities. Since joining the company, Christopher Heery has executed 104 insider transactions totaling $26.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 14, 2026 involved selling 5,882 shares valued at $403.0K.
Christopher Heery currently holds 23,749 shares of PRECISION BIOSCIENCES INC (DTIL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Heery has been a net seller of DTIL stock. They have purchased $30.0K and sold $26.9M worth of shares.
Christopher Heery's most recent insider trade was on Jan 14, 2026, when they sold 5,882 shares at $68.51 per share.
Get notified when new Form 4 filings are submitted
| $65.51 |
| Discretionary |
| Jan 12, 2026 | ACLX | $393.3K | Sale | 6,131 | $64.15 | Discretionary |
| Jan 6, 2026 | ACLX | $0 | Option Exercise | 13,064 | $N/A | Discretionary |
| Jan 3, 2026 | ACLX | $0 | Option Exercise | 16,520 | $N/A | Discretionary |
| Jan 2, 2026 | ACLX | $0 | Option Exercise | 13,021 | $N/A | Discretionary |
| Nov 17, 2025 | ACLX | $30.6K | Sale | 340 | $90.00 | Discretionary |
| Sep 30, 2025 | ACLX | $426.9K | Sale | 5,300 | $80.55 | Discretionary |
| Sep 30, 2025 | ACLX | $1.2M | Sale | 14,204 | $81.46 | Discretionary |
| Sep 30, 2025 | ACLX | $125.8K | Sale | 1,530 | $82.20 | Discretionary |
| Sep 29, 2025 | ACLX | $5.9K | Sale | 73 | $80.16 | Discretionary |
| Sep 26, 2025 | ACLX | $993.2K | Sale | 12,396 | $80.12 | Discretionary |
| Sep 19, 2025 | ACLX | $24.0K | Sale | 300 | $80.00 | Discretionary |
| Sep 18, 2025 | ACLX | $267.5K | Sale | 3,343 | $80.01 | Discretionary |
| Sep 5, 2024 | ACLX | $239.5K | Sale | 3,421 | $70.02 | Planned |
| Sep 5, 2024 | ACLX | $51.3K | Option Exercise | 3,421 | $15.00 | Planned |
| Sep 3, 2024 | ACLX | $976.0K | Sale | 14,776 | $66.05 | Planned |
| Sep 3, 2024 | ACLX | $203.2K | Sale | 2,900 | $70.07 | Planned |
| Sep 3, 2024 | ACLX | $82.9K | Sale | 1,200 | $69.06 | Planned |
| Sep 3, 2024 | ACLX | $133.2K | Sale | 1,958 | $68.01 | Planned |
| Sep 3, 2024 | ACLX | $34.2K | Option Exercise | 5,451 | $6.28 | Planned |
| Sep 3, 2024 | ACLX | $330.0K | Option Exercise | 22,000 | $15.00 | Planned |
| Sep 3, 2024 | ACLX | $444.9K | Sale | 6,617 | $67.24 | Planned |
| Aug 26, 2024 | ACLX | $454.2K | Sale | 6,432 | $70.61 | Planned |
| Aug 26, 2024 | ACLX | $1.1M | Sale | 15,252 | $71.34 | Planned |
| Aug 26, 2024 | ACLX | $325.3K | Option Exercise | 21,684 | $15.00 | Planned |
| Aug 16, 2024 | ACLX | $354.5K | Sale | 5,450 | $65.05 | Planned |
| Aug 16, 2024 | ACLX | $34.2K | Option Exercise | 5,450 | $6.28 | Planned |
| Aug 1, 2024 | ACLX | $1.2M | Sale | 19,268 | $60.39 | Planned |
| Aug 1, 2024 | ACLX | $44.7K | Sale | 732 | $61.13 | Planned |